UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

       Date of Report (date of earliest event reported): October 23, 2015


                                 AMERICANN, INC.
                     --------------------------------------
             (Exact name of registrant as specified in its charter)

         Delaware                     000-54231                27-4336843
  ------------------------        ----------------          ----------------
(State or other jurisdiction    (Commission File No.)     (IRS Employer
  of incorporation)                                        Identification No.)

                          3200 Brighton Blvd., Unit 144
                                Denver, CO 80216
                   ------------------------------------------
          (Address of principal executive offices, including Zip Code)


       Registrant's telephone number, including area code: (303) 862-9000


          (Former name or former address if changed since last report)

Check appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below)

[ ]  Written communications pursuant to Rule 425 under the Securities Act (17
     CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
     240.14a-12)

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement communications pursuant to Rule 13e-14(c) under the
     Exchange Act (17 CFR 240.13e-4(c))

<PAGE>

Item 8.01.  Other Events

     On November 2, 2015,  AmeriCann  appointed Dr. Rien Havens to the Company's
Advisory  Board to assist in the areas of  extraction,  laboratory  design,  and
infused  product  development.  Dr.  Havens  specializes  in plant  medicine and
product  development,  with almost a decade of experience  designing  extraction
systems,  end  products,  conducting  product and process  research and creating
innovative  strategies  for the cannabis  industry.  Dr. Havens has created new,
patent  pending  extraction  technologies,  and has developed  product lines for
health and wellness industries.

Item 1.01.  Entry Into a Material Definitive Agreement

Massachusetts Medical Cannabis Center

     Previously  the Company  entered  into an agreement to purchase a 52.6 acre
parcel of undeveloped land in Freetown,  Massachusetts.  The property is located
approximately  47 miles  southeast of Boston.  The Company  plans to develop the
property as the Massachusetts Medical Cannabis Center "MMCC". Plans for the MMCC
may include the construction of sustainable greenhouse cultivation,  processing,
and  infused  product  facilities  that  will be  leased  or sold to  Registered
Marijuana Dispensaries under the Massachusetts Medical Marijuana Program.

     The Company  paid the seller  $100,000  upon the  signing of the  agreement
which amount will be applied  toward the  purchase  price of  $4,000,000  at the
closing.  Pursuant to the original agreement the closing was to take place on or
before  June 1, 2015.  On May 6, 2015,  to address  site  considerations  before
finalizing  the planned  development,  the  agreement  was amended to extend the
closing date to September 1, 2015. On August 27, 2015, after addressing the site
considerations,  the agreement was amended to extend the closing date to October
30, 2015 to provide  additional  time for  permitting.  In connection  with this
amendment,  the Company paid the seller an additional  $100,000.  On October 23,
2015,  the Company made an additional  payment of $100,000 to extend the closing
date to  December  29,  2015.  All  payments  made by the  Company to the seller
($300,000)  will be applied to the purchase  price.  On November  6th,  2015 the
Company  filed  a  Site  Plan  Application  to the  Town  of  Freetown  Planning
Department.  The Planning  Board will review the MMCC project on November  24th,
2015.

Note Payable

     The Company has adjusted the loan terms from  Strategic  Capital  Partners,
LLC. As of September 30, 2015 the Company had borrowed $1,682,849 from Strategic
Capital Partners. The loan is unsecured and bears interest at 5% per year. Under
the new terms of the loan, interest is payable, or may be added to the principal
balance of the loan, on March 31 and September 30 of each year.  The loan,  plus
all unpaid  principal and interest,  is now due on December 31, 2016.  Strategic
Capital  Partners is  controlled  by Benjamin J.  Barton,  one of the  Company's
officers and directors.

Item 1.02.  Termination of a Material Definitive Agreement

     In August 2015 the Company  signed an agreement to sell a 5-acre  parcel of
property located in north central Denver, Colorado for a total purchase price of
$2,500,000.  The  closing  of the  transaction  was to take  place on or  before
September 14th,  2015, but was extended to November 1, 2015. The Buyer failed to
close the loan on November 1, 2015 and the agreement was terminated.

<PAGE>


                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Date: November 11, 2015
                                      AMERICANN, INC.


                                      By: /s/ Timothy Keogh
                                          ------------------------------------
                                          Timothy Keogh, Chief Executive Officer
[{"type": "8-K", "sequence": "1", "filename": "form8kitem801rien11-15.txt", "description": "FORM 8-K ITEM 8.01", "secsgml_size_bytes": 5918}]
{"company-data": {"conformed-name": "AmeriCann, Inc.", "cik": "0001508348", "assigned-sic": "8742", "irs-number": "274336843", "state-of-incorporation": "DE", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-54231", "film-number": "151222727"}, "business-address": {"street1": "3200 BRIGHTON BLVD.", "street2": "UNIT 114", "city": "DENVER", "state": "CO", "zip": "80216", "phone": "303-898-9832"}, "mail-address": {"street1": "3200 BRIGHTON BLVD.", "street2": "UNIT 114", "city": "DENVER", "state": "CO", "zip": "80216"}, "former-company": [{"former-conformed-name": "Americann, Inc.", "date-changed": "20140516"}, {"former-conformed-name": "Nevada Health Scan, Inc.", "date-changed": "20101220"}]}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

       Date of Report (date of earliest event reported): October 23, 2015

                                 AMERICANN, INC.
                     --------------------------------------
             (Exact name of registrant as specified in its charter)

         Delaware                     000-54231                27-4336843
  ------------------------        ----------------          ----------------
(State or other jurisdiction    (Commission File No.)     (IRS Employer
  of incorporation)                                        Identification No.)

                          3200 Brighton Blvd., Unit 144
                                Denver, CO 80216
                   ------------------------------------------
          (Address of principal executive offices, including Zip Code)

       Registrant's telephone number, including area code: (303) 862-9000

          (Former name or former address if changed since last report)

Check appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below)

[ ]  Written communications pursuant to Rule 425 under the Securities Act (17
     CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
     240.14a-12)

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement communications pursuant to Rule 13e-14(c) under the
     Exchange Act (17 CFR 240.13e-4(c))
Item 8.01.  Other Events

     On November 2, 2015,  AmeriCann  appointed Dr. Rien Havens to the Company's
Advisory  Board to assist in the areas of  extraction,  laboratory  design,  and
infused  product  development.  Dr.  Havens  specializes  in plant  medicine and
product  development,  with almost a decade of experience  designing  extraction
systems,  end  products,  conducting  product and process  research and creating
innovative  strategies  for the cannabis  industry.  Dr. Havens has created new,
patent  pending  extraction  technologies,  and has developed  product lines for
health and wellness industries.

Item 1.01.  Entry Into a Material Definitive Agreement

Massachusetts Medical Cannabis Center

     Previously  the Company  entered  into an agreement to purchase a 52.6 acre
parcel of undeveloped land in Freetown,  Massachusetts.  The property is located
approximately  47 miles  southeast of Boston.  The Company  plans to develop the
property as the Massachusetts Medical Cannabis Center "MMCC". Plans for the MMCC
may include the construction of sustainable greenhouse cultivation,  processing,
and  infused  product  facilities  that  will be  leased  or sold to  Registered
Marijuana Dispensaries under the Massachusetts Medical Marijuana Program.

     The Company  paid the seller  $100,000  upon the  signing of the  agreement
which amount will be applied  toward the  purchase  price of  $4,000,000  at the
closing.  Pursuant to the original agreement the closing was to take place on or
before  June 1, 2015.  On May 6, 2015,  to address  site  considerations  before
finalizing  the planned  development,  the  agreement  was amended to extend the
closing date to September 1, 2015. On August 27, 2015, after addressing the site
considerations,  the agreement was amended to extend the closing date to October
30, 2015 to provide  additional  time for  permitting.  In connection  with this
amendment,  the Company paid the seller an additional  $100,000.  On October 23,
2015,  the Company made an additional  payment of $100,000 to extend the closing
date to  December  29,  2015.  All  payments  made by the  Company to the seller
($300,000)  will be applied to the purchase  price.  On November  6th,  2015 the
Company  filed  a  Site  Plan  Application  to the  Town  of  Freetown  Planning
Department.  The Planning  Board will review the MMCC project on November  24th,
2015.

Note Payable

     The Company has adjusted the loan terms from  Strategic  Capital  Partners,
LLC. As of September 30, 2015 the Company had borrowed $1,682,849 from Strategic
Capital Partners. The loan is unsecured and bears interest at 5% per year. Under
the new terms of the loan, interest is payable, or may be added to the principal
balance of the loan, on March 31 and September 30 of each year.  The loan,  plus
all unpaid  principal and interest,  is now due on December 31, 2016.  Strategic
Capital  Partners is  controlled  by Benjamin J.  Barton,  one of the  Company's
officers and directors.

Item 1.02.  Termination of a Material Definitive Agreement

     In August 2015 the Company  signed an agreement to sell a 5-acre  parcel of
property located in north central Denver, Colorado for a total purchase price of
$2,500,000.  The  closing  of the  transaction  was to take  place on or  before
September 14th,  2015, but was extended to November 1, 2015. The Buyer failed to
close the loan on November 1, 2015 and the agreement was terminated.
SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

Date: November 11, 2015
                                      AMERICANN, INC.

                                      By: /s/ Timothy Keogh
                                          ------------------------------------
                                          Timothy Keogh, Chief Executive Officer